Anti-EphB6 antibody

Cat.#: 141675

Special Price 145.0 USD

Availability:
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-EphB6 antibody
  • Documents
  • Description
    Rabbit Polyclonal to Mouse EphB6
  • Tested applications
    IHC-P
  • Species reactivity
    Mouse EphB6 / Eph Receptor B6
  • Alternative names
    HEP antibody; Cekl antibody; Cekl antibody; Ephb6 antibody; EphB6 antibody; HEP antibody; Mep antibody; MGC129910 antibody; MGC129911 antibody; MEP antibody
  • Immunogen
  • Isotype
    Rabbit IgG
  • Preparation
    Produced in rabbits immunized with purified, recombinant Mouse EphB6 / Eph Receptor B6 . EphB6 / Eph Receptor B6 specific IgG was purified by Mouse EphB6 / Eph Receptor B6 affinity chromatography.
  • Clonality
    Polyclonal
  • Formulation
    0.2 μm filtered solution in PBS
  • Storage instructions
    This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free.
    Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
  • Applications

    IHC-P: 0.1-2 μg/mL

  • Validations

    Mouse EphB6/Eph Receptor B6 Immunohistochemistry(IHC) 14747

    Mouse EphB6/Eph Receptor B6 Immunohistochemistry(IHC) 14747

  • Background
    Ephrins are divided into the ephrin-A (EFNA) class and the ephrin-B (EFNB) class based on their structures and sequence relationships. Ephrin receptors make up the largest subgroup of the receptor tyrosine kinase (RTK) family. EphB6 is an unusual Eph receptor, lacking catalytic capacity due to alterations in its kinase domain. Interestingly, increased metastatic activity is associated with reduced EphB6 receptor expression in several tumor types, including breast cancer. This emphasizes the potential of EphB6 to act as a suppressor of cancer aggressiveness. EphB6 suppress cancer invasiveness through c-Cbl-dependent signaling, morphologic changes, and cell attachment and indicate that EphB6 may represent a useful prognostic marker and a promising target for therapeutic approaches. EphB6 can both positively and negatively regulate cell adhesion and migration, and suggest that tyrosine phosphorylation of the receptor by an Src family kinase acts as the molecular switch for the functional transition. In addition, Ephrin-B2 may be a physiological ligand for the EphB6 receptor.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"